Schrodinger, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Schrodinger has 4 disclosed suppliers and 8 disclosed customers in SEC filings.
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+8.60%
vs ±12.1% implied · ×0.71
shaded = implied · ▲▼ = realized
Schrodinger, Inc.
27.14
SentenceThe project is being funded initially by $19.5 million in grants from the Bill & Melinda Gates Foundation.
SDGR 10-Kaccession 0001490978-26-000010
SentenceIn particular, the technology that we license from Columbia University pursuant to our license agreements with them are used in and incorporated into a number of our software solutions which we market and license to our customers.
SDGR 10-Kaccession 0001490978-26-000010
SentenceThe agreement with Gates Ventures, LLC was originally entered into in June 2020 and further extended through August 13, 2026.
SDGR 10-Kaccession 0001490978-26-000010
SentenceIn 2023, on account of our equity stake in Nimbus Therapeutics, LLC, or Nimbus, we received an aggregate of $147.2 million in cash distributions from Nimbus in connection with Takeda's acquisition of Nimbus Lakshmi, Inc., a wholly-owned subsidiary of Nimbus, and its TYK2 inhibitor NDI-034858.
SDGR 10-Kaccession 0001490978-26-000010
SentenceWe are party to an exclusive, worldwide collaboration and license agreement with BMS, pursuant to which we and BMS agreed to collaborate in the discovery, research and development of small molecule compounds for biological targets in the oncology, neurology and immunology therapeutic areas.
SentenceIn September 2022, we entered into a collaboration with Lilly under which we are responsible for the discovery and optimization of small molecule compounds addressing an immunology target.
SentenceFor example, in 2023, we entered into a research collaboration with Copernic Catalysts, Inc. to help accelerate the discovery and development of sustainable catalysts for applications in e-fuels and bulk chemicals.
SDGR 10-Kaccession 0001490978-26-000010
SentenceAs part of our ongoing efforts to further advance our software solutions for materials science applications, in June 2020, we entered into a three-year agreement with Gates Ventures, LLC, or Gates Ventures, to develop and apply atomistic simulations methods to improve battery performance.
SDGR 10-Kaccession 0001490978-26-000010
SentenceWe are also entitled to low single-digit royalties on our clinical development programs under our collaboration agreement with Morphic, including MORF-057.
SDGR 10-Kaccession 0001490978-26-000010
SentenceFor example, in collaboration with us, Nimbus was able to identify a unique series of acetyl-CoA carboxylase, or ACC, allosteric protein-protein interaction inhibitors with favorable pharmaceutical properties that inhibit the activity of the ACC enzyme.
SDGR 10-Kaccession 0001490978-26-000010
SentenceIn January 2025, we announced that we have expanded the collaboration with Otsuka to add an undisclosed target to the collaboration.
SDGR 10-Kaccession 0001490978-26-000010
Linked news
Expected move
Inputs8Q avg ±5.1%·×2.62·rich
straddle ±18.1%
spot 27.14exp Nov 20ATM strike 27.5ATM straddle 5.77IV 110%